These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2507819)

  • 81. Antimicrobial synergism against Mycobacterium avium complex strains isolated from patients with acquired immune deficiency syndrome.
    Yajko DM; Kirihara J; Sanders C; Nassos P; Hadley WK
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1392-5. PubMed ID: 3196000
    [TBL] [Abstract][Full Text] [Related]  

  • 82. In vitro antimycobacterial activities of capuramycin analogues.
    Reddy VM; Einck L; Nacy CA
    Antimicrob Agents Chemother; 2008 Feb; 52(2):719-21. PubMed ID: 18070956
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Activities of fluoroquinolone, macrolide, and aminoglycoside drugs combined with inhibitors of glycosylation and fatty acid and peptide biosynthesis against Mycobacterium avium.
    Barrow WW; Wright EL; Goh KS; Rastogi N
    Antimicrob Agents Chemother; 1993 Apr; 37(4):652-61. PubMed ID: 8494359
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Susceptibility of mycobacteria to fusidic acid.
    Hoffner SE; Olsson-Liljequist B; Rydgård KJ; Svenson SB; Källenius G
    Eur J Clin Microbiol Infect Dis; 1990 Apr; 9(4):294-7. PubMed ID: 2112466
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Activity of aminosidine (paromomycin) for Mycobacterium tuberculosis and Mycobacterium avium.
    Kayok TP; Reddy MV; Chinnaswamy J; Danziger LH; Gangadharam PR
    J Antimicrob Chemother; 1994 Feb; 33(2):323-7. PubMed ID: 8182014
    [No Abstract]   [Full Text] [Related]  

  • 86. A luciferase-based method for assessing chlorine-susceptibility of Mycobacterium avium.
    Cowan HE; Falkinham JO
    J Microbiol Methods; 2001 Sep; 46(3):209-15. PubMed ID: 11438185
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Action of 1-isonicotinyl-2-palmitoyl hydrazine against the Mycobacterium avium complex and enhancement of its activity by m-fluorophenylalanine.
    Rastogi N; Goh KS
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2061-4. PubMed ID: 2073098
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Evidence suggesting that the life span of Mycobacterium avium complex is longer than that of other mycobacteria.
    Tsukamura M
    Microbiol Immunol; 1988; 32(8):769-74. PubMed ID: 3200167
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Resistance and permeability of Mycobacterium avium complex species to 5-fluorouracil.
    Abdulmalek S; McCarthy CM
    J Antimicrob Chemother; 1994 Feb; 33(2):329-35. PubMed ID: 8182015
    [No Abstract]   [Full Text] [Related]  

  • 90. [ON THE WATER-SOLUBILITY OF LONG-ACTING SULFA DRUG PREPARATIONS AND THEIR ANTITUBERCULAR ACTION].
    MIYABAYASHI Y; KOBAYASHI T; HOSHINO S; OGAWA S; HAYASAKA H
    Iryo; 1963 Oct; 17():641-2. PubMed ID: 14092810
    [No Abstract]   [Full Text] [Related]  

  • 91. Radiometric quantification of Mycobacterium avium complex.
    Haug CJ; Gaustad P; Müller F
    Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):388-90. PubMed ID: 9758276
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Effect of simultaneous administration of drugs on absorption and excretion. 3. Effect of non-steroidal anti-inflammatory agents and sulfadimethoxine N4-acetate on antibacterial activity of sulfadimethoxine in vitro (author's transl)].
    Imamura Y; Ichibagase H
    Yakugaku Zasshi; 1973 Sep; 93(9):1206-210. PubMed ID: 4797578
    [No Abstract]   [Full Text] [Related]  

  • 93. Contribution of N4-acetylsulfadimethoxine to the interaction of sulfadimethoxine with ketoprofen in rabbits.
    Imamura Y; Mori H; Otagiri M
    Chem Pharm Bull (Tokyo); 1987 Mar; 35(3):1299-303. PubMed ID: 3607955
    [No Abstract]   [Full Text] [Related]  

  • 94. Anticryptosporidial activity of sulfadimethoxine.
    Rekg JE; Hancock ML; Woodmansee DB
    Antimicrob Agents Chemother; 1988 Dec; 32(12):1907-8. PubMed ID: 3245702
    [No Abstract]   [Full Text] [Related]  

  • 95. [Studies on the metabolism of sulfadimethoxine. IV. Sulfadimethoxine-N1-glucuronamide].
    Kushima T
    Yakugaku Zasshi; 1967 May; 87(5):603-5. PubMed ID: 4864759
    [No Abstract]   [Full Text] [Related]  

  • 96. [Basic study on topical use of chemotherapeutics. 3. Sulfadimethoxine and sulfisomezole].
    Rokukawa Y
    Shigaku; 1967 Jun; 55(1):23-42. PubMed ID: 4867773
    [No Abstract]   [Full Text] [Related]  

  • 97. Correction to: Low serum estradiol levels are related to Mycobacterium avium complex lung disease: a cross-sectional study.
    Uwamino Y; Nishimura T; Sato Y; Tamizu E; Asakura T; Uno S; Mori M; Fujiwara H; Ishii M; Kawabe H; Murata M; Hasegawa N
    BMC Infect Dis; 2020 Feb; 20(1):131. PubMed ID: 32050914
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [A supplement study on the in vitro activity of sulfadimethoxine on Mycobacterium avium complex--combined effect with other antituberculosis drugs].
    Tsukamura M
    Kekkaku; 1989 Jun; 64(6):379-86. PubMed ID: 2507819
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Determination of the susceptibilities to antituberculosis agents in Mycobacterium avium-Mycobacterium intracellulare complex].
    Tsukamura M
    Kekkaku; 1990 Jul; 65(7):471-5. PubMed ID: 2214509
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [Cross-resistance relationships of antituberculosis drugs in Mycobacterium avium complex].
    Tsukamura M
    Kekkaku; 1989 Jan; 64(1):1-5. PubMed ID: 2709652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.